Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
KLRA · against 588 other Healthcare companies listed in US-listed
Ranked #571 of 589 · scores higher than 0% of peers
Bars: peers in each 10-point band of the valuation score277 peers with a valuation score of 0–9, including KLRA · Click a bar to see the companies
Mainly because of its EBITDA yield and earnings yield, which are weaker than most Healthcare peers.
| Metric | KLRA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 577 reported | -18.6% | -4.3% | 23% | 30% | |
| EBITDA yieldHigher is better · 578 reported | -43.2% | -0.8% | 11% | 50% | |
| Free cash flow yieldHigher is better · 553 reported | Not reported | -2.3% | — | — | 20% |
| Book yieldHigher is better · 587 reported | 68.6% | 25.9% | 83% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 256M USD | 98 | 80 | |
| 2 | 595M USD | 96 | 97 | |
| 2 | 433M USD | 96 | 81 | |
| 2 | 289M USD | 96 | 57 | |
| 2 | 810M USD | 96 | 69 | |
| 571 | 1.8B USD | 0 | 30 | |
| 571 | 952M USD |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 0 |
| 3 |
| 571 | 1.4B USD | 0 |
| 571 | 1.3B USD | 0 |
| 571 | 1.6B USD | 0 |
| 571 | 332M USD | 0 | 35 |
| 571 | 1.0B USD | 0 | 32 |
| 571 | 3.6B USD | 0 |
| 571 | 3.0B USD | 0 | 11 |